| Bioactivity | Pyr1]-Apelin-13, Gly(15N) TFA is a Gly15N labeled [Pyr1]-Apelin-13. [Pyr1]-Apelin-13 is a highly potent, selective endogenous apelin receptor agonist[1][2]. |
| Sequence | {Glp}-Arg-Pro-Arg-Leu-Ser-His-Lys--{Gly(15N)}-Pro-Met-Pro-Phe |
| Shortening | {Glp}-RPRLSHK-{Gly(15N)}-PMPF |
| Formula | C69H108N2115NO16S.xC2HF3O2 |
| Molar Mass | 1534.79 (free base) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Serpooshan V, et al. [Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction. Biomaterials. 2015 Jan;37:289-98. [2]. Hajimashhadi Z, et al. Chronic administration of [Pyr1] apelin-13 attenuates neuropathic pain after compression spinal cord injury in rats. Neuropeptides. 2017 Feb;61:15-22. |
[Pyr1]-Apelin-13, Gly(15N) TFA
CAS: F: C69H108N2115NO16S.xC2HF3O2 W: 1534.79 (free base)
Pyr1]-Apelin-13, Gly(15N) TFA is a Gly15N labeled -Apelin-13. -Apelin-13 is a highly potent, selective endogenous apelin
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.